S. Tazzyman

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S Tazzyman, S. Tazzyman, Simon Tazzyman, Simon J. Tazzyman
Publication record
38 papers · 4,061 citations · H-index 22

PAPERS

An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy
20251 citationsauthor #2
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
20235 citationsauthor #1
HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England.
20232 citationsauthor #25
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
2021560 citationsauthor #251
Detection and mapping of haemoglobin variants in blood fingermarks by MALDI MS for suspect "profiling".
202111 citationsauthor #5
Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors
202028 citationsauthor #16
The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation
201917 citationsauthor #2
Bone Research Society, Annual Meeting 2017 Proceedings
20181 citationsauthor #268
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models
201834 citationsauthor #2
Myeloma-Specific Oncolytic Adenovirus Induces Significant Tumour Oncolysis In Vitro and In Vivo and Prevents Cell Line Regrowth
20182 citationsauthor #2
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
2018459 citationsauthor #6
Zebrafish xenograft models of cancer and metastasis for drug discovery
201796 citationsauthor #3
Zebrafish as a new model to study effects of periodontal pathogens on cardiovascular diseases
201628 citationsauthor #3
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.
2015438 citationsauthor #7
The application of antibotoxsome, a novel cytotoxic conjugate, in cell death in in vitro models of pancreatic, liver, breast, cervical cancer, and myeloma.
20150 citationsauthor #1
Explorer Stimulation of Tumor Relapse After Chemotherapy by Perivascular , Alternatively Activated Macrophages
20150 citationsauthor #7
Development of a Trojan horse oncolytic virus for treatment of myeloma.
20153 citationsauthor #1
Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial
201544 citationsauthor #1
Macrophage-mediated response to hypoxia in disease
201418 citationsauthor #1
Zebrafish tissue injury causes upregulation of interleukin-1 and caspase-dependent amplification of the inflammatory response
201385 citationsauthor #4
Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.
2013133 citationsauthor #1
Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation.
201392 citationsauthor #6
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.
2013126 citationsauthor #18
Loss of Function of Parathyroid Hormone Receptor 1 Induces Notch-Dependent Aortic Defects During Zebrafish Vascular Development
201316 citationsauthor #8
Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2‐specific antagonist is associated with reduced tumor growth
2011104 citationsauthor #1
A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo
201020 citationsauthor #5
Neutrophils: key mediators of tumour angiogenesis
2009321 citationsauthor #1
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors
2009183 citationsauthor #4
Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner.
200840 citationsauthor #2
Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.
2008219 citationsauthor #2
Their Responses to Angiopoietin-2 Expression of Tie-2 by Human Monocytes
20070 citationsauthor #3
Identification of key residues involved in mediating the in vivo anti‐tumor/anti‐endothelial activity of Alphastatin
200713 citationsauthor #5
Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-21
2007350 citationsauthor #2
OC9 ALPHASTATIN, A 24-AMINO ACID FRAGMENT OF FIBRINOGEN IS A NOVEL ANTI-ANGIOGENIC AND ANTI-VASCULAR AGENT
20041 citationsauthor #5
Current methods for assaying angiogenesis in vitro and in vivo
2004372 citationsauthor #3
Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro
2004116 citationsauthor #2
Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo.
200460 citationsauthor #5
Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.
200064 citationsauthor #2

TIMELINE

2000 64 citations

2004 549 citations

2007 363 citations

2008 259 citations

2009 504 citations

2010 20 citations

2011 104 citations

2013 452 citations

2014 18 citations

2015 485 citations

2016 28 citations

2017 96 citations

2018 496 citations

2019 17 citations

2020 28 citations

2021 571 citations

2023 7 citations

2025 1 citations

S. Tazzyman

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT